ArcticZymes Technologies ASA (AZT.OL)
NOK 13.58
(-2.3%)
NOK 13.58
(-2.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 118.93 Million NOK | -13.16% |
| 2022 | 136.97 Million NOK | 7.03% |
| 2021 | 127.97 Million NOK | 36.94% |
| 2020 | 93.44 Million NOK | 20.97% |
| 2019 | 77.24 Million NOK | 15.69% |
| 2018 | 66.76 Million NOK | 0.12% |
| 2017 | 66.68 Million NOK | -7.26% |
| 2016 | 71.9 Million NOK | 34.95% |
| 2015 | 53.28 Million NOK | 61.33% |
| 2014 | 33.02 Million NOK | 49.38% |
| 2013 | 22.1 Million NOK | 2.95% |
| 2012 | 21.47 Million NOK | -6.76% |
| 2011 | 23.03 Million NOK | -11.1% |
| 2010 | 25.9 Million NOK | 7.62% |
| 2009 | 24.07 Million NOK | -53.44% |
| 2008 | 51.7 Million NOK | -29.39% |
| 2007 | 73.21 Million NOK | 0.33% |
| 2006 | 72.97 Million NOK | 4.19% |
| 2005 | 70.04 Million NOK | -52.42% |
| 2004 | 147.2 Million NOK | 103.53% |
| 2003 | 72.32 Million NOK | 937.75% |
| 2002 | 6.96 Million NOK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 29.99 Million NOK | 5.68% |
| 2024 Q2 | 26.5 Million NOK | -11.63% |
| 2023 Q2 | 28.21 Million NOK | -9.53% |
| 2023 Q1 | 31.18 Million NOK | 12.4% |
| 2023 Q4 | 28.38 Million NOK | -8.9% |
| 2023 FY | 118.93 Million NOK | -13.16% |
| 2023 Q3 | 31.15 Million NOK | 10.39% |
| 2022 Q1 | 49.18 Million NOK | 29.06% |
| 2022 Q2 | 30.33 Million NOK | -38.33% |
| 2022 FY | 136.97 Million NOK | 7.03% |
| 2022 Q3 | 29.7 Million NOK | -2.09% |
| 2022 Q4 | 27.74 Million NOK | -6.58% |
| 2021 Q3 | 26.43 Million NOK | 17.94% |
| 2021 Q2 | 22.41 Million NOK | -45.33% |
| 2021 FY | 127.97 Million NOK | 36.94% |
| 2021 Q1 | 41 Million NOK | 321.36% |
| 2021 Q4 | 38.11 Million NOK | 44.15% |
| 2020 FY | 93.44 Million NOK | 20.97% |
| 2020 Q4 | -18.52 Million NOK | -158.71% |
| 2020 Q3 | 31.54 Million NOK | -29.69% |
| 2020 Q2 | 44.87 Million NOK | 26.22% |
| 2020 Q1 | 35.55 Million NOK | 92.91% |
| 2019 Q1 | 15.88 Million NOK | 2.84% |
| 2019 FY | 77.24 Million NOK | 15.69% |
| 2019 Q4 | 18.42 Million NOK | -23.07% |
| 2019 Q3 | 23.95 Million NOK | 26.22% |
| 2019 Q2 | 18.97 Million NOK | 19.49% |
| 2018 FY | 66.76 Million NOK | 0.12% |
| 2018 Q1 | 15.99 Million NOK | 24.81% |
| 2018 Q4 | 15.44 Million NOK | -33.12% |
| 2018 Q3 | 23.09 Million NOK | 88.76% |
| 2018 Q2 | 12.23 Million NOK | -23.52% |
| 2017 Q3 | 16.26 Million NOK | -8.76% |
| 2017 Q2 | 17.83 Million NOK | -2.01% |
| 2017 Q1 | 18.19 Million NOK | -0.1% |
| 2017 FY | 66.68 Million NOK | -7.26% |
| 2017 Q4 | 12.81 Million NOK | -21.21% |
| 2016 Q4 | 18.21 Million NOK | -13.73% |
| 2016 Q3 | 21.11 Million NOK | 37.94% |
| 2016 Q1 | 17.26 Million NOK | 32.18% |
| 2016 Q2 | 15.3 Million NOK | -11.35% |
| 2016 FY | 71.9 Million NOK | 34.95% |
| 2015 Q2 | 11.49 Million NOK | -6.72% |
| 2015 FY | 53.28 Million NOK | 61.33% |
| 2015 Q4 | 13.06 Million NOK | -20.4% |
| 2015 Q1 | 12.31 Million NOK | 22.79% |
| 2015 Q3 | 16.41 Million NOK | 42.82% |
| 2014 Q4 | 10.03 Million NOK | 4.58% |
| 2014 FY | 33.02 Million NOK | 49.38% |
| 2014 Q3 | 9.59 Million NOK | 3.15% |
| 2014 Q2 | 9.3 Million NOK | 126.77% |
| 2014 Q1 | 4.1 Million NOK | -22.8% |
| 2013 Q3 | 6.34 Million NOK | 38.73% |
| 2013 Q4 | 5.31 Million NOK | -16.31% |
| 2013 FY | 22.1 Million NOK | 2.95% |
| 2013 Q1 | 5.87 Million NOK | -2.57% |
| 2013 Q2 | 4.57 Million NOK | -22.11% |
| 2012 Q1 | 6.93 Million NOK | 85.93% |
| 2012 Q4 | 6.02 Million NOK | 51.63% |
| 2012 Q3 | 3.97 Million NOK | -12.29% |
| 2012 FY | 21.47 Million NOK | -6.76% |
| 2012 Q2 | 4.53 Million NOK | -34.65% |
| 2011 Q4 | 3.73 Million NOK | -24.53% |
| 2011 Q1 | 8.98 Million NOK | -14.93% |
| 2011 Q2 | 5.36 Million NOK | -40.26% |
| 2011 Q3 | 4.94 Million NOK | -7.92% |
| 2011 FY | 23.03 Million NOK | -11.1% |
| 2010 Q4 | 10.56 Million NOK | 384.19% |
| 2010 Q2 | 7.33 Million NOK | 25.88% |
| 2010 Q1 | 5.82 Million NOK | 0.0% |
| 2010 Q3 | 2.18 Million NOK | -70.25% |
| 2010 FY | 25.9 Million NOK | 7.62% |
| 2009 FY | 24.07 Million NOK | -53.44% |
| 2008 FY | 51.7 Million NOK | -29.39% |
| 2007 FY | 73.21 Million NOK | 0.33% |
| 2006 FY | 72.97 Million NOK | 4.19% |
| 2005 FY | 70.04 Million NOK | -52.42% |
| 2004 FY | 147.2 Million NOK | 103.53% |
| 2003 FY | 72.32 Million NOK | 937.75% |
| 2002 FY | 6.96 Million NOK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Arctic Bioscience AS | 33.75 Million NOK | -252.412% |
| Aqua Bio Technology ASA | 1.55 Million NOK | -7525.747% |
| BerGenBio ASA | 354 Thousand NOK | -33498.588% |
| Hofseth BioCare ASA | 194.87 Million NOK | 38.966% |
| PCI Biotech Holding ASA | 2.99 Million NOK | -3877.893% |
| Thor Medical ASA | - NOK | -Infinity% |
| Ultimovacs ASA | - NOK | -Infinity% |